Hong Liang Selected Research

thiosemicarbazide

12/2020	Synthesis of a series of novel In(III) 2,6-diacetylpyridine bis(thiosemicarbazide) complexes: structure, anticancer function and mechanism.
1/2016	Multidrug Delivery Systems Based on Human Serum Albumin for Combination Therapy with Three Anticancer Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Liang Research Topics

Disease

141	Neoplasms (Cancer) 04/2022 - 07/2002
18	Inflammation (Inflammations) 01/2022 - 01/2002
17	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2012
12	Mitochondrial Diseases (Mitochondrial Disease) 06/2022 - 03/2015
9	Neoplasm Metastasis (Metastasis) 04/2022 - 11/2012
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2012
8	Carcinoma (Carcinomatosis) 01/2022 - 01/2009
8	Glioma (Gliomas) 11/2020 - 10/2011
7	Dry Eye Syndromes (Dry Eye Syndrome) 10/2022 - 10/2005
7	Hypoxia (Hypoxemia) 01/2022 - 10/2011
7	Infections 01/2021 - 04/2015
6	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 01/2017
6	Keshan disease 12/2021 - 01/2019
6	Tuberculosis (Tuberculoses) 01/2021 - 10/2010
6	Glaucoma 06/2017 - 12/2004
5	Pain (Aches) 10/2021 - 03/2007
5	Leukemia 01/2021 - 10/2007
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2009
5	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 01/2015
4	Obesity 06/2022 - 12/2017
4	Urinary Bladder Neoplasms (Bladder Cancer) 04/2022 - 10/2019
4	Lung Neoplasms (Lung Cancer) 03/2022 - 10/2012
4	COVID-19 01/2022 - 01/2021
4	Malaria 01/2020 - 04/2011
4	Wounds and Injuries (Trauma) 01/2017 - 01/2012
4	Liver Neoplasms (Liver Cancer) 01/2016 - 02/2011
3	Hypertension (High Blood Pressure) 01/2022 - 01/2020
3	Carcinogenesis 12/2021 - 09/2002
3	Corneal Injuries 10/2021 - 07/2007
3	Acidosis 01/2021 - 09/2017
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2014
3	Cystinosis 01/2021 - 01/2017
3	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 02/2011
3	Photophobia (Light Sensitivity) 12/2018 - 05/2015
3	Visceral Leishmaniasis (Kala Azar) 01/2017 - 07/2011

Drug/Important Bio-Agent (IBA)

31	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 06/2010
24	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2008
13	CopperIBA 04/2022 - 03/2015
11	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2015
11	LigandsIBA 05/2021 - 01/2009
10	Human Serum Albumin FDA LinkGeneric 01/2022 - 03/2015
10	AntigensIBA 01/2022 - 10/2008
10	PlatinumIBA 10/2021 - 06/2013
10	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
9	VaccinesIBA 01/2022 - 07/2011
9	Biomarkers (Surrogate Marker)IBA 09/2021 - 07/2012
8	Biological ProductsIBA 01/2019 - 09/2004
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2011
7	MetalsIBA 01/2021 - 02/2012
7	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2019 - 03/2015
6	CarbonIBA 01/2022 - 10/2014
6	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2016
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 10/2014
6	Hyaluronic Acid (Hyaluronan)IBA 05/2019 - 01/2002
5	LipidsIBA 01/2022 - 05/2016
5	Oxygen (Dioxygen)IBA 01/2022 - 11/2017
5	EnzymesIBA 01/2022 - 04/2016
5	Carrier Proteins (Binding Protein)IBA 12/2021 - 06/2010
4	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2018
4	ThiosemicarbazonesIBA 01/2022 - 01/2018
4	Hydroxyl RadicalIBA 01/2022 - 11/2021
4	Glutathione (Reduced Glutathione)IBA 01/2022 - 11/2021
4	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2012
4	PhosphatidylserinesIBA 12/2021 - 10/2011
4	GoldIBA 12/2021 - 01/2018
4	CytokinesIBA 07/2021 - 12/2004
4	SolutionsIBA 01/2021 - 07/2011
4	ProdrugsIBA 10/2020 - 10/2015
4	Cytochromes c (Cytochrome c)IBA 10/2020 - 01/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 11/2006
3	CaspasesIBA 06/2022 - 01/2017
3	Therapeutic UsesIBA 01/2022 - 09/2018
3	quinolineIBA 01/2022 - 12/2019
3	SeleniumIBA 12/2021 - 06/2019
3	Liposomes (Liposome)IBA 10/2021 - 01/2019
3	Selenoprotein PIBA 09/2021 - 01/2019
3	Estrogen ReceptorsIBA 01/2021 - 12/2017
3	Cystine (L-Cystine)IBA 01/2021 - 01/2017
3	Cysteamine (Mercaptamine)FDA Link 01/2021 - 01/2017
3	Peptides (Polypeptides)IBA 01/2021 - 07/2013
3	AcidsIBA 01/2021 - 10/2007
3	Apolipoproteins E (ApoE)IBA 12/2020 - 05/2016
3	Proprotein Convertase 9IBA 01/2020 - 11/2015
3	AdiponectinIBA 01/2020 - 01/2015
3	SaponinsIBA 07/2018 - 05/2006
3	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 09/2005
3	EmulsionsIBA 01/2017 - 08/2009
3	Latanoprost (Xalatan)FDA Link 11/2012 - 01/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2022 - 01/2012

Therapy/Procedure

44	Therapeutics 01/2022 - 10/2008
12	Drug Therapy (Chemotherapy) 01/2022 - 06/2010
8	Photothermal Therapy 01/2022 - 10/2014
8	Phototherapy (Light Therapy) 01/2021 - 11/2014
7	Lasers (Laser) 05/2019 - 05/2015
4	Length of Stay 01/2020 - 02/2011
3	Catheters 06/2022 - 01/2017
3	Metastasectomy 12/2021 - 01/2021
3	Precision Medicine 12/2021 - 05/2018
3	Photochemotherapy (Photodynamic Therapy) 12/2018 - 10/2014
3	Slit Lamp 12/2018 - 12/2007